tiprankstipranks
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
OLMA
Olema Pharmaceuticals
RESEARCH TOOLSreports
Want to see OLMA full AI Analyst Report?

Olema Pharmaceuticals (OLMA) Income Statement

959 Followers

Olema Pharmaceuticals Income Statement

Last quarter (Q4 2025), Olema Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Olema Pharmaceuticals's net income was $-46.06M. See Olema Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 178.70M$ 142.26M$ 104.96M$ 106.99M$ 71.49M
Depreciation and Amortization
$ 490.00K$ 393.00K$ 377.00K$ 357.00K$ 163.00K
EBITDA
$ -178.21M$ -141.87M$ -104.58M$ -106.63M$ -71.33M
Operating Income
$ -178.70M$ -142.26M$ -104.96M$ -106.99M$ -71.49M
Other Income/Expenses
$ 16.25M$ 12.78M$ 8.31M$ 2.20M$ 395.00K
Pretax Income
$ -162.45M$ -129.47M$ -96.66M$ -104.79M$ -71.10M
Net Income
$ -162.45M$ -129.47M$ -96.66M$ -104.79M$ -71.10M
Per Share Metrics
Basic EPS
$ -1.87$ -2.20$ -2.14$ -2.62$ -1.79
Diluted EPS
$ -1.87$ -2.20$ -2.14$ -2.62$ -1.79
Weighted Average Shares Outstanding
 87.01M 58.74M 45.25M 40.00M 39.52M
Weighted Average Shares Outstanding (Diluted)
 87.01M 58.74M 45.25M 40.00M 39.52M
Currency in USD

Olema Pharmaceuticals Earnings and Revenue History